Verigat

Vericiguat INN

CARDIOVASCULAR

INDICATION

rnrn

Verigat is indicated forrnrn

·       rnChronic Heart Failurernrn

·       rnHeart Failure with reduced ejectionrnfraction (<45%)rnrn

·       rnWorsening Heart Failure eventrnrn

DOSAGE AND ADMINISTRATION

rnrn

The recommended starting dose ofrnVerigat is 2.5 mg orally once daily with food. Double the dose of Verigatrnapproximately every 2 weeks to reach the target maintenance dose of 10 mg oncerndaily, as tolerated by the patient. For patients who are unable to swallowrnwhole tablet, Verigat may be crushed and mixed with water immediately beforernadministration. ORrnAS DIRECTED BY THE PHYSICIAN.rnrn

rnrn

COMPOSITION

normal\\\”>mso-ascii-theme-font:minor-latin;mso-hansi-theme-font:minor-latin\\\”>Verigat 2.5 Tablet:
mso-ascii-theme-font:minor-latin;mso-hansi-theme-font:minor-latin\\\”>Each
film-coated tablet contains Vericiguat INN 2.5 mg.

normal\\\”>mso-ascii-theme-font:minor-latin;mso-hansi-theme-font:minor-latin\\\”>Verigat 5 Tablet:
mso-ascii-theme-font:minor-latin;mso-hansi-theme-font:minor-latin\\\”>Each
film-coated tablet contains Vericiguat INN 5 mg.

normal\\\”>mso-ascii-theme-font:minor-latin;mso-hansi-theme-font:minor-latin\\\”>Verigat 10 Tablet:
mso-ascii-theme-font:minor-latin;mso-hansi-theme-font:minor-latin\\\”>Each
film-coated tablet contains Vericiguat INN 10 mg.